Charlotte Parker, Author at Oral Cancer News

Richard Holbrook’s Benefit Concert To Give All Proceeds to The Bruce Paltrow Oral Cancer Fund

NEWPORT BEACH, Calif., July 13, 2017 /PRNewswire-USNewswire/ -- Acclaimed cabaret singer Richard Holbrook will be performing two benefit concerts at the Metropolitan Room in New York City on Friday, September 8, 2017 at 7:00pm and Saturday, September 9, 2017 at 4:00pm as a benefit for The Bruce Paltrow Oral Cancer Fund which is connected with The Oral Cancer Foundation. Holbrook will be singing Richard Rodgers songs from classic Broadway shows and memorable Hollywood film musicals. "I'm so thrilled and excited to be performing my show as a benefit for the Bruce Paltrow Oral Cancer Fund," he states. Holbrook will be accompanied by the fabulous Tom Nelson Trio. The stage 4 oral cancer survivor found a canker sore which led to a cancer diagnosis, spreading from gum to jaw. In September 2013 Holbrook stated, "After the surgery, I couldn't utter a sound. I wrote notes to my family, but they were illegible. I got so frustrated! I now have such empathy for people with conditions that keep them from being able to communicate with the world. One of the most enlightening lessons I learned is how important communication is. As singers, it is all about HOW we communicate through words, sound and storytelling." About Richard Holbrook Born in New York City, Richard taught himself how to sing by listening to the recordings of Fred Astaire, Judy Garland, and Bing Crosby and by watching their films. He found success as an actor on such hit television series as The Sopranos and Spin [...]

Charlotte Parker2017-07-17T11:21:09-07:00July, 2017|Oral Cancer News|

House Committee Looks to Dilute Tobacco Control Act

Source: www.medpagetoday.com Date: July 12, 2017 Author: Salynn Boyles The U.S. House Appropriations Committee made a move Wednesday to greatly weaken the FDA's authority to regulate tobacco products, including flavored cigars and electronic cigarettes, and health advocacy groups were quick to condemn it. The committee approved a rider to the agriculture funding bill that would exempt certain cigars from FDA's authority and weaken its regulatory oversight over e-cigarettes, little cigars, and hookah tobacco. Prior to the vote, the House committee defeated an amendment by Rep. Nita Lowey (D-N.Y.) to remove language from the bill that will effectively eliminate FDA's authority to review the health hazards of thousands of tobacco products. A second rider would exempt from FDA authority certain cigars, including many that are cheap, flavored and are most likely to appeal to children, said American Lung Association (ALA) President Harold Wimmer. "These dangerous riders were added to this bill for the benefit of the tobacco industry and come at a time when e-cigarettes are the most commonly used tobacco product among kids," Wimmer said in a written press statement. The riders are similar to those passed by the House Appropriations Committee last year, but the language restricting FDA's authority under the Tobacco Control Act was dropped from the final FY2017 bill later in the appropriations process. New language in the FY2018 bill does require the FDA to develop standards for the flavors added to e-cigarettes. ALA spokesperson Erika Sward told MedPage Today that it is not clear if the [...]

Charlotte Parker2017-07-13T11:02:13-07:00July, 2017|Oral Cancer News|

Personalized cancer vaccines successful in first-stage human trials

Source: http://newatlas.com/cancer-personalized-vaccine-success-trial/50402/ Author: Rich Haridy Date: July 9, 2017 A cancer vaccine is one of the holy grails of modern medical research, but finding a way to stimulate the immune system to specifically target and kill cancer cells has proven to be a difficult task. Now two recent clinical trials that have produced encouraging results in patients with skin cancer are are providing hope for the development of personalized cancer vaccines tailored to individual patient's tumors. Both studies focus on neoantigens, which are mutated molecules found only on the surface of cancer cells. Neoantigens prove to be ideal targets for immunotherapy as they are not present on healthy cells. A vaccine's challenge is to train the body's immune cells, known as T cells, to hunt and kill only those specific tumor cells that hold the target neoantigens. In the first trial, at Boston's Dana-Farber Cancer Institute, samples of tumors were taken from six patients with melanoma. The patients were identified as having a high risk for recurrence after first having their tumors removed by surgery. For each individual patient the researchers identified up to 20 neoantigens specific to a subject's tumor. Computer algorithms were then utilized to help the researchers select which specific neoantigens would best stimulate the body's T cells. Those neoantigens were then synthesized, mixed with an adjuvant to stimulate immune response, and injected into the individual patients. Four out of the six patients in this first trial displayed no recurrence of their cancer 25 months after vaccination. [...]

Charlotte Parker2017-07-10T09:33:39-07:00July, 2017|Oral Cancer News|

Don’t start, be smart: Local, Reno Rodeo competitor advocates being tobacco-free

Source: mynews4.com Author: Kenzie Bales Date: June 13th, 2017 RENO, Nev. (News 4 & Fox 11) — As a country phenomenon, Garth Brooks once said, "It's bulls and blood, it's dust and mud, it's the roar of a Sunday crowd. It's the white in his knuckles, the gold in the buckle, he'll win the next go 'round. It's boots and chaps, it's cowboy hats, it's spurs and latigo, it's the ropes and the reins, and the joy and the pain and they call the thing rodeo." 2017 Reno Rodeo competitor Cody Z Kiser has been riding and roping for as long as he can remember. Born and raised to Carrie and P.D. Kiser in Carson City, Nevada, Cody started riding bulls as a Dayton High School student. A horrific injury would set Kiser back, but by no means did it keep him from chasing his dreams. Kiser says a bull stepped on his face and crushed all the bones in the left side of his face. After recovering, Kiser transitioned from bull riding to bareback bucking horses and hasn't looked back since. If traveling to rodeos all the time wasn't enough to keep someone completely preoccupied, Cody competed while pursuing a Bachelor's Degree in Civil Engineering at the University of Nevada, Reno. After testing the waters in the engineering field for awhile, Kiser decided it was time to chase his lifelong dream and give rodeo his full attention. During his endeavors as a cowboy, Cody was fortunate enough to establish a [...]

Charlotte Parker2017-06-14T12:17:21-07:00June, 2017|Oral Cancer News|

HPV Vaccination Linked to Decreased Oral HPV Infections

Author: NCI Staff Date: June 5th, 2017 Source: www.cancer.org New study results suggest that vaccination against the human papillomavirus (HPV) may sharply reduce oral HPV infections that are a major risk factor for oropharyngeal cancer, a type of head and neck cancer. The study of more than 2,600 young adults in the United States found that the prevalence of oral infection with four HPV types, including two high-risk, or cancer-causing, types, was 88% lower in those who reported receiving at least one dose of an HPV vaccine than in those who said they were not vaccinated. About 70% of oropharyngeal cancers are caused by high-risk HPV infection, and the incidence of HPV-positive oropharyngeal cancer has been increasing in the United States in recent decades. In the United States, more than half of oropharyngeal cancers are linked to a single high-risk HPV type, HPV 16, which is one of the types covered by Food and Drug Administration (FDA)-approved HPV vaccines. “In an unvaccinated population, we would estimate that about a million young adults would have an oral HPV infection by one of these vaccine HPV types. If they had all been vaccinated, we could have prevented almost 900,000 of those infections,” said senior study author Maura Gillison, M.D., Ph.D., of the University of Texas MD Anderson Cancer Center. Dr. Gillison presented the new findings at a May 17 press briefing ahead of the 2017 annual American Society of Clinical Oncology (ASCO) meeting, held June 2–6 in Chicago. A Rapidly Rising Cancer Oropharyngeal [...]

Charlotte Parker2017-06-05T14:39:41-07:00June, 2017|Oral Cancer News|

Study reveals high environmental cost of tobacco

Source: www.cnn.com Date: May 31st, 2017 Author: Jacopo Prisco Details of the environmental cost of tobacco are revealed in a study released Wednesday by the World Health Organization, adding to the well-known costs to global health, which translate to a yearly loss of $1.4 trillion in health-care expenses and lost productivity. From crop to pack, tobacco commands an intensive use of resources and forces the release of harmful chemicals in the soil and waterways, as well as significant amounts of greenhouse gases. Its leftovers linger, as tobacco litter is the biggest component of litter worldwide. "Tobacco not only produces lung cancer in people, but it is a cancer to the lungs of the Earth," said Dr. Armando Peruga, who previously coordinated the WHO Tobacco Free Initiative and now works as a consultant. He reviewed the new report for the WHO. Commercial tobacco farming is a worldwide industry that involves 124 countries and occupies 4.3 million hectares of agricultural land. About 90% of it takes place in low-income countries, with China, Brazil and India as the largest producers. Because tobacco is often a monocrop -- grown without being rotated with other crops -- the plants and the soil are weak in natural defenses and require larger amounts of chemicals for growth and protection from pests. "Tobacco also takes away a lot of nutrients from the soil and requires massive amounts of fertilizer, a process that leads to degradation of the land and desertification, with negative consequences for biodiversity and wildlife," Peruga [...]

Charlotte Parker2017-05-31T11:27:48-07:00May, 2017|Oral Cancer News|

Recommendation Against Routine Thyroid Cancer Screening Retained

Author: Shreeya Nanda Date: 05/23/2017 Source: https://www.medwirenews.com The decision is based on a systematic review of 67 studies, also reported in JAMA, evaluating various aspects of screening, such as the benefits and harms of screening asymptomatic individuals and of treating screen-detected cancers, as well as the diagnostic accuracy of screening modalities. Although there were no trials directly comparing the benefits of early versus late or delayed treatment, two separate observational studies compared the outcome of treatment versus no surgery or surveillance. However, as neither study accounted for confounding variables, robust conclusions could not be drawn, say Jennifer Lin, from Kaiser Permanente Center for Health Research in Portland, Oregon, USA, and colleagues. By contrast, they identified 52 studies, including 335,091 patients, that provided information on the harms of treating screen-detected thyroid cancers. A meta-analysis of the data showed that the incidence of permanent hypoparathyroidism varied between 2% and 6%, while the rate of permanent vocal cord paralysis ranged from around 1% to 2%. Among patients who received radioactive iodine therapy, the excess absolute risk for secondary cancers ranged from 11.9 to 13.3 per 10,000 person–years. And the incidence of dry mouth ranged widely, from approximately 2% to 35%. The USPSTF commissioned the systematic review due to the rising incidence of thyroid cancers against a background of stable mortality, which is suggestive of overdiagnosis. And in view of the results, the task force concluded with “moderate certainty” that the harms outweigh the benefits of screening, upholding the “D” recommendation. The USPSTF emphasizes, [...]

Charlotte Parker2017-05-23T12:36:12-07:00May, 2017|Oral Cancer News|

Large Study Shows Reduced Oral HPV Infections With Vaccine

Author: Kate Johnson Date: May 18, 2017 Source: http://www.medscape.com/viewarticle/880184#vp_1 Human papillomavirus (HPV) vaccination is associated with an 88% reduction in rates of oral HPV infection according to one of the first studies to investigate this association. The findings, reported in a premeeting presscast for the American Society of Clinical Oncology (ASCO) 2017 Annual Meeting, suggest that HPV vaccination may play an important role in the prevention of oropharyngeal cancer. "Our data indicate that HPV vaccines have tremendous potential to prevent oral infections," said senior study author Maura L. Gillison, MD, PhD, who conducted the research at Ohio State University and is now a professor of medicine at the University of Texas MD Anderson Cancer Center in Houston. But she emphasized that although more than 90% of oropharangeal cancers are caused by HPV-16 ― one of the types for which HPV vaccines are currently available ― the vaccine is only indicated for the prevention of cervical and anogenital infections and associated cancers. "There haven't been any clinical trials evaluating whether the currently approved HPV vaccines can prevent oral infections that lead to cancer, so that is not currently an indication," she explained. In the absence of randomized trials, Dr Gillison and colleagues carried out a cross-sectional study using data from the National Health and Nutrition Examination Survey (NHANES) survey collected from 2627 young adults aged 18 to 33 years during the period 2011-2014. This study was conducted by the National Center for Health Statistics and was designed to assess the health and wellness [...]

Charlotte Parker2017-10-29T20:13:57-07:00May, 2017|Oral Cancer News|

Is the HPV vaccine safe?

Author: Linda Carroll Date: May 15, 2017 Source: http://www.today.com/health/hpv-vaccine-who-should-get-it-t110710 There is so much confusion around the human papillomavirus, or HPV: what it is, what causes it, how you can prevent it, and most commonly, whether or not the HPV vaccine is actually safe. Here are the basics: According to the Centers for Disease Control and Prevention, HPV is a group of more than 150 related viruses. It's transmitted through intimate skin-to-skin contact, and you can get it by having vaginal, anal or oral sex with someone else who has the virus. It is very common: A recent report found 42 percent of Americans are infected with HPV. That may sound alarming, but in most cases, HPV goes away without any signs and doesn't lead to health issues. When HPV doesn't go away, it can lead to genital warts and cancer. It's important to note 25 percent of men and 20 percent of women between the ages of 18 and 59 are infected with the cancer-causing strains. So what can you do? The best way to prevent these harmful types of HPV is to get the HPV vaccine, which was first recommended in 2006, but people are still wary of it. “This is the only vaccine we have that prevents cancer,” said Dr. Donnica Moore, president of the Sapphire Women’s Health Group. The HPV vaccine protects against strains of the virus that have been shown to cause cervical, vaginal, vulvar and penile cancer, as well as certain cancers of the mouth [...]

Charlotte Parker2017-05-16T08:48:40-07:00May, 2017|Oral Cancer News|

‘Happy Days’ star Erin Moran’s Husband Reveals Tragic Details about Cancer

Author: Marah Alindogan Source: www.aol.com Date: Apr 25th 2017 Erin Moran's husband, Steve Fleischmann, revealed heartbreaking details about the months leading up to her death in a Facebook post on Tuesday. New evidence from the Harrison County Sheriff's Office on Monday suggested that the actress likely died due to complications from stage 4 cancer. The open letter, which was posted on Scott Baio's official Facebook page, confirmed the report. "Erin and I met 4/22/1992 and parted ways 4/22/2017," her husband began the letter. He recalled that Erin "woke up and had about a dime size blood stain on her pillowcase" right after they got back from a trip to celebrate their wedding anniversary in November of last year. After a couple of days, they kept on finding more blood. "I get a flashlight and say let me look. It was not her tongue it was her tonsil on the left side. I thought it was tonsillitis," wrote Fleischmann. After getting a biopsy, doctors confirmed she had squamous cell carcinoma -- a common form of cancer. Shortly after, she started radiation and chemo -- five days a week on radiation and chemo only on Thursdays. However, Erin's condition slowly deteriorated: "It got so bad so fast. By the middle of February, Erin could no longer speak or eat or drink." Despite her poor health, the actress remained in good spirits. "She was still happy, she was active, she texted people on her phone all day," Steve added. The day before her [...]

Charlotte Parker2017-04-25T11:18:44-07:00April, 2017|Oral Cancer News|

Oral Cancer News
Compiled by The Oral Cancer Foundation

About Charlotte Parker